Background information about Barcelona and Idibaps
Barcelona is the capital of Catalonia and the second largest city in Spain, with a population above 1,5 million. It is the sixth-most populous urban area in the European Union after Paris, London, Ruhr area, Madrid and Milan. About 5 million people live in the Barcelona metropolitan area. It is also Europe’s largest metropolis on the Mediterranean coast. Barcelona is recognised as a Global City due to its importance in finance, commerce, media, entertainment, arts, international trade, education and tourism. Indeed, it is a major economic centre and a growing financial center, one of Europe’s principal Mediterranean ports.
Barcelona enjoys a Mediterranean climate. The summer’s season lasts about 6 months, from May to October, although also in November and April sometimes there are temperatures above 20 °C. Winters are mild, with average temperatures over 14.5 °C during the day and 5.5 °C at night in the period December to March.
IDIBAPS is a public consortium that was formed in 1996 by the Catalan Government, a University Hospital (Hospital Clinic Provincial de Barcelona, HCPB) listed as the best hospital in Spain with national and international recognition, the University of Barcelona (only Spanish university included in the ranking of the best 200 worldwide) and the Biomedical Research Institute from the Spanish Research Council (CSIC). IDIBAPS is a highly active Research Organization, recognized both nationally and internationally, that combines Health Care with the Research. We are located in the heart of Barcelona, one of the most dynamic cities in the Mediterranean.
The research activities of the Centre are divided into 6 different areas, which include more than 50 top-level research teams. Scientific breakthroughs are never the result of chance. They are long-term commitments that involve not only researchers, but also society as a whole. IDIBAPS is a consortium that assumes one of these commitments in Catalonia: To encourage translational research, innovation and technological progress in the field of biomedicine, through different programmes addressing diseases with a high prevalence, morbidity and mortality. Our goal, making people’s health better.